ROSSITTO, GIACOMO
 Distribuzione geografica
Continente #
NA - Nord America 6.081
AS - Asia 3.807
EU - Europa 1.743
SA - Sud America 655
AF - Africa 642
OC - Oceania 68
Continente sconosciuto - Info sul continente non disponibili 27
Totale 13.023
Nazione #
US - Stati Uniti d'America 5.692
SG - Singapore 1.171
CN - Cina 649
HK - Hong Kong 504
VN - Vietnam 456
BR - Brasile 394
IT - Italia 317
FI - Finlandia 161
DE - Germania 138
FR - Francia 135
IN - India 131
GB - Regno Unito 113
SE - Svezia 103
PL - Polonia 99
RU - Federazione Russa 95
BD - Bangladesh 91
IQ - Iraq 71
NL - Olanda 67
AR - Argentina 59
CA - Canada 56
JP - Giappone 55
TR - Turchia 50
MX - Messico 49
PK - Pakistan 49
PH - Filippine 48
EC - Ecuador 40
ZA - Sudafrica 39
SA - Arabia Saudita 38
UZ - Uzbekistan 38
ID - Indonesia 37
UA - Ucraina 36
UG - Uganda 34
ES - Italia 33
MY - Malesia 33
JM - Giamaica 29
AU - Australia 27
PA - Panama 27
PY - Paraguay 27
CZ - Repubblica Ceca 26
DZ - Algeria 26
CO - Colombia 25
CY - Cipro 25
IE - Irlanda 25
MA - Marocco 25
KR - Corea 24
NP - Nepal 24
CL - Cile 23
LB - Libano 23
AE - Emirati Arabi Uniti 22
BJ - Benin 22
JO - Giordania 22
NI - Nicaragua 22
PT - Portogallo 22
AZ - Azerbaigian 21
EE - Estonia 21
PE - Perù 21
RS - Serbia 21
BE - Belgio 20
BY - Bielorussia 20
KE - Kenya 20
LY - Libia 20
AT - Austria 19
BO - Bolivia 19
BZ - Belize 19
ET - Etiopia 19
GM - Gambi 19
TN - Tunisia 19
BA - Bosnia-Erzegovina 18
CH - Svizzera 18
HU - Ungheria 18
KG - Kirghizistan 18
MD - Moldavia 18
SK - Slovacchia (Repubblica Slovacca) 18
TH - Thailandia 18
TT - Trinidad e Tobago 18
BF - Burkina Faso 17
CV - Capo Verde 17
MN - Mongolia 17
MR - Mauritania 17
PR - Porto Rico 17
VE - Venezuela 17
AL - Albania 16
CI - Costa d'Avorio 16
CU - Cuba 16
EG - Egitto 16
GE - Georgia 16
GN - Guinea 16
IL - Israele 16
KZ - Kazakistan 16
LC - Santa Lucia 16
NO - Norvegia 16
AO - Angola 15
CW - ???statistics.table.value.countryCode.CW??? 15
DO - Repubblica Dominicana 15
HN - Honduras 15
MK - Macedonia 15
MZ - Mozambico 15
BG - Bulgaria 14
CD - Congo 14
GH - Ghana 14
Totale 12.363
Città #
Ashburn 762
Singapore 712
San Jose 675
Fairfield 575
Hong Kong 470
Woodbridge 288
Ann Arbor 248
Houston 247
Chandler 246
Seattle 188
Cambridge 172
Beijing 160
Wilmington 154
Los Angeles 151
Ho Chi Minh City 139
Helsinki 104
Santa Clara 104
Chicago 100
Boardman 96
Hanoi 94
New York 91
Padova 79
Council Bluffs 71
Lauterbourg 67
Bytom 63
San Diego 60
Medford 52
Princeton 49
Munich 44
Buffalo 43
Salt Lake City 40
São Paulo 37
Roxbury 35
Baghdad 34
Tokyo 34
Des Moines 33
Kampala 33
Orem 31
Tashkent 31
Guangzhou 29
Nanjing 26
Panama City 26
Chennai 24
Haiphong 24
Dublin 22
Hefei 22
Tampa 22
Atlanta 21
Da Nang 21
Johannesburg 21
Managua 21
Milan 21
Amman 20
Brooklyn 20
Cotonou 20
Montreal 20
The Dalles 20
Warsaw 20
Dong Ket 19
London 19
Kingston 18
Lahore 18
Amsterdam 17
Denver 17
Lappeenranta 17
Nairobi 17
Rio de Janeiro 17
Stockholm 17
Ulan Bator 17
Conakry 16
Havana 16
Jeddah 16
Kuala Lumpur 16
Nuremberg 16
Padua 16
Abidjan 15
Addis Ababa 15
Castries 15
Elk Grove Village 15
Limassol 15
Phoenix 15
Toronto 15
Baku 14
Dallas 14
Istanbul 14
Jacksonville 14
Maputo 14
Nouakchott 14
Ouagadougou 14
Podgorica 14
Quito 14
Redondo Beach 14
Seoul 14
Tallinn 14
Tripoli 14
Bamako 13
Bridgetown 13
Brno 13
Frankfurt am Main 13
Lima 13
Totale 7.673
Nome #
Exclusion Tests in Unilateral Primary Aldosteronism (ExcluPA) Study 375
Lymphatic vessels and the renin-angiotensin-system 318
Quantitative Value of Aldosterone-Renin Ratio for Detection of Aldosterone-Producing Adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) Study 307
Assessment of the Quantitative Value Usefulness of the Aldosterone-Renin Ratio (ARR) for Primary Aldosteronism (AQUARR) Study 268
A sleep apnoea questionnaire predicts organ damage in hypertensive patients 268
Lipoprotein-associated phospholipase A2 activity predicts cardiovascular events in high risk coronary artery disease patients. 264
Practice Recommendations for Diagnosis and Treatment of the Most Common Forms of Secondary Hypertension 263
High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension. 259
Management of hypertensive emergencies: a practical approach 249
The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism 238
The Intra-Procedural Cortisol Assay During Adrenal Vein Sampling: Rationale and Design of a Randomized Study (I-Padua) 237
Subtyping of Primary Aldosteronism in the AVIS-2 Study: Assessment of Selectivity and Lateralization 233
Clinical Outcomes of 1625 Patients with Primary Aldosteronism Subtyped with Adrenal Vein Sampling 229
Prospective validation of an automated chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension 227
Subtyping of primary aldosteronism with adrenal vein sampling: Hormone- and side-specific effects of cosyntropin and metoclopramide 226
'Essential' arterial hypertension: time for a paradigm change 226
Subtype Identification of Surgically Curable Primary Aldosteronism During Treatment With Mineralocorticoid Receptor Blockade 225
Resolution of Drug-Resistant Hypertension by Adrenal Vein Sampling-guided Adrenalectomy: A Proof-of-Concept Study 224
Lipoprotein-associated phospholipase A2 single-nucleotide polymorphisms and cardiovascular events in patients with coronary artery disease. 221
AT1AA (Angiotensin II Type-1 Receptor Autoantibodies): Cause or Consequence of Human Primary Aldosteronism? 220
Systolic and diastolic short-term blood pressure variability and its determinants in patients with controlled and uncontrolled hypertension: A retrospective cohort study 219
Galectin-3 predicts long-term cardiovascular death in high-risk patients with coronary artery disease. 218
Feasibility of imaging-guided adrenalectomy in young patients with primary aldosteronism 216
Antibodies to malondialdehyde oxidized low-density lipoproteins predict long term cardiovascular mortality in high risk patients. 210
Effects of mineralocorticoid and AT-1 receptor antagonism on the aldosterone–renin ratio (ARR) in primary aldosteronism patients (EMIRA Study): rationale and design 210
The subtyping of primary aldosteronism by adrenal vein sampling: Sequential blood sampling causes factitious lateralization 209
Antihypertensive therapy in patients on chronic lithium treatment for bipolar disorders 207
Treatment of atherosclerotic renovascular hypertension: review of observational studies and a meta-analysis of randomized clinical trials. 203
Identification of Surgically Curable Primary Aldosteronism by Imaging in a Large Multiethnic International Study 200
A meta-analysis of somatic KCNJ5 K+ channel mutations in 1636 patients with an aldosterone-producing adenoma 199
Adrenal venous sampling in dye-allergic primary aldosteronism patients: prevalence, pitfalls and a possible solution 192
Drug-resistant hypertension in primary aldosteronism patients undergoing adrenal vein sampling: the AVIS-2-RH study 187
Modern Management of Hypertensive Emergencies 184
Oral burning with dysphagia and weight loss 183
Metoclopramide unmasks potentially misleading contralateral suppression in patients undergoing adrenal vein sampling for primary aldosteronism 183
LB02.07: EFFECT OF ACUTE DA2 DOPAMINERGIC RECEPTOR BLOCKADE ON PERFORMANCE OF ADRENAL VEIN SAMPLING FOR SUBTYPING OF PRIMARY ALDOSTERONISM 179
Elevation of Angiotensin-II Type-1-Receptor Autoantibodies Titer in Primary Aldosteronism as a Result of Aldosterone-Producing Adenoma. 177
Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study 176
Primary Aldosteronism and Drug Resistant Hypertension: A "Chicken-Egg" Story 171
Androstenedione and 17-α-Hydroxyprogesterone Are Better Indicators of Adrenal Vein Sampling Selectivity Than Cortisol 166
Tangram of Sodium and Fluid Balance 165
A Worrying and Puzzling Case of Hypertension Presenting to the Emergency Department 164
Cell-mediated autoimmune mechanisms involved in the pathogenesis of primary aldosteronism. 159
Excessive daytime sleepiness does not correlate with sympathetic nervous system activation and arterial stiffening in patients with mild-to-moderate obstructive sleep apnoea: A proof-of-principle study 158
Life-threatening coagulopathy and hypofibrinogenaemia induced by tigecycline in a patient with advanced liver cirrhosis. 152
Adrenal venous sampling but not computed tomography is essential before undertaking adrenalectomy for primary aldosteronism 149
Clinical Management of Primary Aldosteronism: An Update 146
Unilaterally Selective Adrenal Vein Sampling for Identification of Surgically Curable Primary Aldosteronism 144
Reduced Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction 144
The role of oxidized low-density lipoproteins in atherosclerosis: The myths and the facts 140
Coronary sinus diameter to estimate congestion and predict survival 136
Skin-specific mechanisms of body fluid regulation in hypertension 135
Tissue sodium excess is not hypertonic and reflects extracellular volume expansion 135
Letter to the Editor From Paolo Rossi and Rossitto: "Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism" 134
Sodium, Interstitium, Lymphatics and Hypertension-A Tale of Hydraulics 129
Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complications. 129
Subtyping of Primary Aldosteronism by Adrenal Venous Sampling 125
Management and Outcomes of Primary Aldosteronism in Pregnancy: A Systematic Review 122
Q: Should alpha-blockers ever be used as antihypertensive drugs? 122
Does Excess Tissue Sodium Storage Regulate Blood Pressure? 119
Pathophysiology of Hypertension 112
Aldosterone and Cardiovascular Damage: a New Lesson From an Old Study 109
Haemodynamic assessment in hypertension: the soloists and the orchestra 108
Antibodies to malondialdehyde oxidized LDL predict cardiovascular events during long-term follow-up in high risk coronary artery disease patients. 107
Ipertensione e surrene 105
Much Ado about N⋯ atrium: Modelling tissue sodium as a highly sensitive marker of subclinical and localized oedema 103
Dr Giacomo Rossitto interviews Professor Rhian Touyz, on the translational applications of vascular smooth muscle cell biology in cardiovascular disease 102
Antihypertensive Drugs and Vascular Health 99
Salt loading decreases urinary excretion and increases intracellular accumulation of uromodulin in stroke-prone spontaneously hypertensive rats 95
Excessive daytime sleepiness, sympathetic nervous system activation and arterial stiffening in patients with mild-to-moderate obstructive sleep apnoea. Reply 91
The Lymphatic System 89
Mechanisms of sodium-mediated injury in cardiovascular disease: old play, new scripts 79
Response to the letter regarding the hypothesis paper “Much ado about N . . . Atrium: Modelling tissue sodium as a highly sensitive marker of subclinical and localised oedema” 78
Of Snails, Earthworms, and Men: Insights into Strategies to Preserve Water 72
How Blood Pressure Tracks-Salty and Secondary Causes 21
Lymphangioplasty 4.0 as a therapeutic and educational opportunity for (Lymph)edema 19
Totale 13.162
Categoria #
all - tutte 37.140
article - articoli 35.824
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.316
Totale 74.280


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021209 0 0 0 0 0 0 0 0 0 0 0 209
2021/2022707 24 45 38 62 62 93 37 52 48 54 34 158
2022/2023570 114 46 26 44 86 58 7 44 80 27 26 12
2023/2024345 16 40 42 32 17 41 23 15 21 13 33 52
2024/20251.834 12 148 96 43 185 43 166 161 116 130 278 456
2025/20267.644 408 512 993 1.358 938 391 952 619 772 410 244 47
Totale 13.162